Nattokinase/Serrapeptase Combination

What is Nattokinase/Serrapeptase Combination?

Nattokinase is a protein-digesting enzyme extracted from natto, a fermented soybean dish that has been eaten in Japan for over a thousand years. Serrapeptase is produced by bacteria originally found in the gut of silkworms and has been used widely in European and Asian clinical settings since the 1970s for its strong anti-inflammatory and fibrin-dissolving properties. Together, they form a complementary enzyme pair that works on blood clot material, scar tissue, and inflammatory proteins through slightly different but overlapping pathways.

How does Nattokinase/Serrapeptase Combination work?

Nattokinase directly breaks down fibrin — the stringy protein that makes blood clots and arterial plaques stiff and sticky — and also activates the body's own clot-dissolving system. Serrapeptase chews through dead tissue, fibrin, and inflammatory proteins (like bradykinin and cytokines) and is especially good at thinning thick mucus. Used together, they hit the fibrin-inflammation cycle from two angles, which is why many practitioners combine them rather than use either alone.

What forms does Nattokinase/Serrapeptase Combination come in?

Enteric-coated or delayed-release capsules are non-negotiable for this combination — regular capsules will allow stomach acid to break down the enzymes before they can be absorbed. Some products use vegetable cellulose delayed-release capsules; others use a hard tablet with an enteric coating. Both formats work well. Liquid or powder forms of these enzymes are generally not viable for oral use.

Where it comes from:

Natto has been a staple of Japanese Buddhist monastery cuisine since at least the 11th century, and nattokinase was isolated and named by researcher Hiroyuki Sumi in 1980 after he observed natto dissolving fibrin in a petri dish. Serrapeptase was identified in the 1960s and became widely used in Japan, Germany, and Italy as a prescription or over-the-counter anti-inflammatory agent for post-surgical swelling and sinusitis before gaining popularity in the English-speaking supplement market.

What does Nattokinase/Serrapeptase Combination help with?

• Cardiovascular health and blood clot risk: Nattokinase is the standout here — it directly dissolves the fibrin mesh that holds blood clots together and helps keep arterial walls cleaner. Several human studies have shown measurable reductions in clotting markers and improvements in blood flow after regular nattokinase use. Serrapeptase adds to this by clearing inflammatory proteins from vessel walls.
• High blood pressure: Nattokinase has shown blood-pressure-lowering effects in human trials, likely by improving blood vessel flexibility and reducing the fibrin buildup that makes vessel walls stiffer. The combination may also help by easing low-grade vascular inflammation, which is one driver of elevated blood pressure.
• Chronic sinus congestion and rhinosinusitis: Serrapeptase is particularly good at breaking down the thick mucus and scar tissue that keeps sinuses blocked in chronic cases. A handful of clinical trials have found it more effective than placebo for reducing sinus congestion, facial pain, and mucus thickness in people with chronic sinusitis.
• Deep vein thrombosis (DVT) prevention: Nattokinase has been specifically studied for its ability to reduce the risk of economy-class syndrome (blood clots from long flights) and DVT in high-risk individuals. Its fibrin-dissolving action works similarly to pharmaceutical thrombolytics but at a gentler, preventive level.
• Post-surgical or post-injury swelling: Serrapeptase has been used in European clinical settings for decades to reduce post-operative swelling, bruising, and pain. It works by breaking down the proteins that accumulate at injury sites and cause fluid retention. Several controlled trials in dental and orthopedic surgery have shown meaningful reductions in swelling compared to placebo.
• Fibromyalgia and chronic pain: Both enzymes reduce circulating inflammatory proteins that amplify pain signals. Serrapeptase in particular has shown pain-reducing effects in musculoskeletal conditions, likely by clearing the build-up of inflammatory mediators around nerves and connective tissue.
• Atherosclerosis and arterial plaque: Nattokinase may help slow or modestly reduce atherosclerotic plaque by dissolving the fibrin component of plaques and inhibiting platelet clumping. One human trial specifically measured carotid plaque thickness and found a reduction after nattokinase supplementation.
• Endometriosis and uterine fibroids: Some practitioners use systemic enzyme combinations to reduce fibrin-related scar tissue and lesions associated with endometriosis and fibroids. The evidence here is mostly clinical observation and mechanistic reasoning, but the fibrin-dissolving and anti-inflammatory actions of this pair make them a logical tool in integrative management.
• Long COVID and spike protein concerns: Interest in nattokinase for post-COVID microclotting has grown significantly since 2021. Nattokinase has been proposed to help clear the fibrin-heavy microclots documented in long COVID patients, and early research is underway. This remains an emerging area with preliminary but promising mechanistic support.
• Chronic inflammation: Serrapeptase breaks down several inflammatory proteins and has been shown to reduce markers of systemic inflammation in clinical settings. The combination addresses both the fibrin and protein-debris components of chronic inflammatory states, which often feed each other.

What can Nattokinase/Serrapeptase Combination help prevent?

• Recurrent deep vein thrombosis in high-risk individuals
• Travel-related blood clots (economy-class syndrome) during long-haul flights
• Post-surgical adhesion formation

Which foods are rich in Nattokinase/Serrapeptase Combination?

1. Natto (fermented soybeans): The only direct whole-food source of nattokinase — a single 100g serving contains meaningful fibrinolytic activity. Serrapeptase has no food equivalent.
2. Fermented black soybeans (douchi): A related fermented soybean product that contains some fibrinolytic enzyme activity, though significantly less than natto.
3. Ginger: Naturally inhibits platelet clumping and has mild blood-thinning properties that complement the fibrinolytic actions of this enzyme pair.
4. Garlic: Contains allicin, which supports healthy blood viscosity and reduces fibrinogen levels, working along the same cardiovascular pathway as nattokinase.
5. Turmeric (with black pepper): Curcumin reduces systemic inflammation and has mild antiplatelet activity, supporting the anti-inflammatory arm of what this enzyme combination targets.

Practical Tips:

Nattokinase is found only in natto — eating it regularly (even 2–3 times per week) provides genuine fibrinolytic benefit. Serrapeptase has no dietary source. The supportive foods listed help address blood viscosity and chronic inflammation through complementary but distinct mechanisms. A whole-food, Mediterranean-style diet that limits processed foods, refined carbs, and seed oils reduces the chronic fibrin-promoting inflammation that makes this enzyme combination most necessary.

What are the side effects of Nattokinase/Serrapeptase Combination?

• Increased bruising or bleeding (most important risk)
• Nausea or mild stomach upset, especially if taken without enteric coating
• Skin rash or itching (rare hypersensitivity, mainly with serrapeptase)
• Muscle aches (rare, reported with high-dose serrapeptase in a small number of cases)
• Diarrhea or loose stools at higher doses
• Headache (uncommon, typically early in use)
• Allergic reaction in people with soy sensitivity (nattokinase component)

Good to know:

Both enzymes are generally well tolerated by healthy adults. The main safety concern is their blood-thinning effect — this combination is not appropriate for people with bleeding disorders, those on anticoagulants, or anyone scheduled for surgery within two weeks.

How much Nattokinase/Serrapeptase Combination should you take?

• Recommended daily: Nattokinase: 2,000–4,000 FU daily. Serrapeptase: 20,000–60,000 SPU (approximately 10–30 mg) daily. Most combination products provide both in a single capsule taken 1–2 times per day.
• Best time of day: Between meals — ideally at least 45–60 minutes before eating or 2 hours after. Both enzymes need to be absorbed on an empty stomach to reach systemic circulation rather than being used to digest food.
• With or without food: Always take away from food. Taking with food wastes both enzymes on digestion rather than systemic action. Enteric coating is essential — do not open capsules.
• Time to effect: Anti-inflammatory and mucus effects may be felt within 1–2 weeks. Cardiovascular and fibrinolytic benefits typically take 4–12 weeks of consistent use to measure.
• How long to take it: For cardiovascular support, many practitioners use continuous daily dosing for 3–6 months, then reassess. For acute inflammation (post-injury or post-surgical), a focused 4–8 week course is more typical. Cycling (e.g., 8 weeks on, 2 weeks off) is sometimes recommended for long-term use, though formal guidance is limited. Discontinue at least 2 weeks before any surgical procedure.